Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Przyborek

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Schmerz (Berlin, Germany)|September 12, 2024
[New recommendations on palliative sedation]Séverine Marie Surges, Holger Brunsch, Marta Przyborek, et al.
Investigational New Drugs|July 6, 2012
Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomasTanja Trarbach, Marta Przyborek, Norbert Schleucher, et al.
Indian Journal of Palliative Care|September 13, 2023
Development of Care Pathway for Assessment and Treatment of Fatigue in Palliative CareMochamat Mochamat, Marta Przyborek, Birgit Jaspers, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Schmerz (Berlin, Germany)|September 12, 2024
[New recommendations on palliative sedation]Séverine Marie Surges, Holger Brunsch, Marta Przyborek, et al.
Investigational New Drugs|July 6, 2012
Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomasTanja Trarbach, Marta Przyborek, Norbert Schleucher, et al.
Indian Journal of Palliative Care|September 13, 2023
Development of Care Pathway for Assessment and Treatment of Fatigue in Palliative CareMochamat Mochamat, Marta Przyborek, Birgit Jaspers, et al.
Pageof 1